USPTO serial 79269809
CELLIGENICS ENABLING CELLULAR THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2020
- Examiner
- MUCHA, JOHN EVAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CELLIGENICS ENABLING CELLULAR THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David J. Byer
David J. Byer K&L Gates LLPOne Lincoln StreetBoston, MA 02111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research for product development in stem cell biology, stem cells and their derivatives, stem cell commercialization methods, ancillary techniques and cell manufacturing services; industrial analysis, namely, quality and performance profiling of stem cells and their derivatives for standards development, comparison to standards and industrial research services in the field of cell and molecular biology, stem cells and their derivatives, research and analysis for standards development and quality control; stem cell research; stem cell research services; medical research services; biological research services; pharmaceutical research services; scientific research services; medical laboratory services; biochemistry research services; scientific research and industrial research services in the field of stem cell biology for clinical, cosmeceutical and biotech applications; pharmaceutical research and development services; scientific research for medical purposes; scientific laboratory services; provision of information relating to scientific research; provision of information relating to technological research in the field of stem cell biology, stem cells and their derivatives, molecular and cell biology, immunology, cancer biology and methods of use of stem cells and their derivatives in clinical, cosmeceutical and biotech applications | ACTIVE | — |
| 044 | Medical services; personal hygienic and beauty care for human beings; medical services relating to the removal, treatment and processing of stem cells; medical advisory services; medical analysis services for diagnostics and treatment purposes provided by medical laboratories; medical assistance services; medical care services; medical diagnostic services; medical information services; medical and healthcare services; medical testing for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celligenics Pte. Ltd.
- Other trademarks owned by Celligenics Pte. Ltd.
- Other trademarks owned by Celligenics Pte. Ltd.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELLIGENICS ENABLING CELLULAR THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 12, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 4, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 4, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 15, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 15, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 10, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 10, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 10, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 26, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 5, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 5, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 24, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 20, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |